UBS Group
ARWR icon

UBS Group’s Arrowhead Research ARWR Stock Holding History

UBS Group’s Portfolio ARWR Stock Details ARWR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-100
Closed -$1K – 8464
2015
Q1 		$1K Sell
100
-33,700
-100% -$239K ﹤0.01% 8552
2014
Q4 		$249K Buy
+33,800
New +$230K ﹤0.01% 4829

Other funds holding ARWR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

UBS Group's ARWR Position: Q1 2026 in Review

UBS Group increased its Arrowhead Research (ARWR) stake by 35% in Q1 2026, buying an estimated $22.1M and bringing the position to 1,336,271 shares worth $83.8M. The position accounts for 0.01% of the portfolio, ranked #1192.

UBS Group first reported a position in ARWR in Q4 2014 and has held it in 46 quarters since. 436 funds tracked by Wall St. Rank hold ARWR as of Q1 2026.

  • UBS Group held 1,336,271 shares of Arrowhead Research worth $83.8M as of Q1 2026.
  • UBS Group bought 348,984 Arrowhead Research shares in Q1 2026, an estimated $22.1M.
  • Arrowhead Research made up 0.01% of UBS Group's portfolio in Q1 2026, its #1192 holding.
  • UBS Group first reported a position in Arrowhead Research in Q4 2014 and has held it in 46 quarters since.
  • 436 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.